Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intepirdine (RVT-101) in mild-to-moderate Alzheimer's disease patients on donepezil completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• Intepirdine (invoked as intepirdine)
• RVT-101 (intepirdine)

Snippet

Sponsor: Axovant Sciences Ltd. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-12-05